An individual applies for a comprehensive life insurance policy and explicitly denies any history of cardiovascular disease on Part II of the application. A few days later, the home office receives a Medical Information Bureau (MIB) report containing a code that indicates the applicant was recently evaluated for a severe heart arrhythmia by another member company. Under current industry regulations, which of the following is the underwriter's legally permissible course of action regarding this discrepancy?
- Initiate a further investigation by ordering an Attending Physician's Statement (APS) to obtain clinical details, provided the applicant has signed a HIPAA-compliant authorization.Cevap
- BDecline the risk outright based solely on the MIB data and send the applicant an adverse action disclosure as mandated by the Fair Credit Reporting Act (FCRA).
- CTerminate the application immediately, as the applicant's statements are legally considered warranties and any undisclosed medical history automatically voids the contract.
- DInstruct the writing agent to unilaterally amend the medical history section of the original application to reflect the MIB code before issuing a substandard policy.
Cevap
Initiate a further investigation by ordering an Attending Physician's Statement (APS) to obtain clinical details, provided the applicant has signed a HIPAA-compliant authorization.
The correct answer acknowledges that an MIB report cannot be used as the sole reason to decline an applicant. Instead, it serves as a red flag prompting the underwriter to gather more specific evidence. Ordering an Attending Physician's Statement (APS) is the standard procedure to investigate medical discrepancies, and doing so legally requires the applicant's HIPAA-compliant written consent.
Adım Adım Çözüm
Anahtar Kavram
Underwriting Information Sources and Privacy Regulations (MIB, APS, and HIPAA)